Actinium Pharmaceuticals, Inc. Insider Trading for April 2016

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Actinium Pharmaceuticals, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Actinium Pharmaceuticals, Inc. for April 2016.

<<< Back to the month list

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 26 2016CTVNActinium Pharmaceu ...Memorial Sloan-Kettering Cance ...10% OwnerSellS1.972,5004,9255,453,3135.5 M to 5.5 M (-0.05 %)
Apr 26 2016CTVNActinium Pharmaceu ...Memorial Sloan-Kettering Cance ...10% OwnerSellS1.954,0007,8005,455,8135.5 M to 5.5 M (-0.07 %)
Apr 26 2016CTVNActinium Pharmaceu ...Memorial Sloan-Kettering Cance ...10% OwnerSellS2.062,4084,9605,459,8135.5 M to 5.5 M (-0.04 %)
Apr 26 2016CTVNActinium Pharmaceu ...Memorial Sloan-Kettering Cance ...10% OwnerSellS2.053,4006,9705,462,2215.5 M to 5.5 M (-0.06 %)
Apr 26 2016CTVNActinium Pharmaceu ...Memorial Sloan-Kettering Cance ...10% OwnerSellS2.028771,7725,465,6215.5 M to 5.5 M (-0.02 %)
Apr 26 2016CTVNActinium Pharmaceu ...Memorial Sloan-Kettering Cance ...10% OwnerSellS2.021,2002,4185,466,4985.5 M to 5.5 M (-0.02 %)
Apr 26 2016CTVNActinium Pharmaceu ...Memorial Sloan-Kettering Cance ...10% OwnerSellS2.014008055,467,6985.5 M to 5.5 M (-0.01 %)
Apr 26 2016CTVNActinium Pharmaceu ...Memorial Sloan-Kettering Cance ...10% OwnerSellS2.017,60015,2765,468,0985.5 M to 5.5 M (-0.14 %)
Apr 26 2016CTVNActinium Pharmaceu ...Memorial Sloan-Kettering Cance ...10% OwnerSellS2.015001,0035,475,6985.5 M to 5.5 M (-0.01 %)
Apr 26 2016CTVNActinium Pharmaceu ...Memorial Sloan-Kettering Cance ...10% OwnerSellS2.002004015,476,1985.5 M to 5.5 M (0.00 %)
Apr 26 2016CTVNActinium Pharmaceu ...Memorial Sloan-Kettering Cance ...10% OwnerSellS2.001,8003,6005,476,3985.5 M to 5.5 M (-0.03 %)
Apr 26 2016CTVNActinium Pharmaceu ...Memorial Sloan-Kettering Cance ...10% OwnerSellS2.091002095,478,1985.5 M to 5.5 M (0.00 %)
Apr 26 2016CTVNActinium Pharmaceu ...Memorial Sloan-Kettering Cance ...10% OwnerSellS2.083,6927,6795,478,2985.5 M to 5.5 M (-0.07 %)
Apr 26 2016CTVNActinium Pharmaceu ...Memorial Sloan-Kettering Cance ...10% OwnerSellS2.081,0002,0755,481,9905.5 M to 5.5 M (-0.02 %)
Apr 26 2016CTVNActinium Pharmaceu ...Memorial Sloan-Kettering Cance ...10% OwnerSellS2.071002075,482,9905.5 M to 5.5 M (0.00 %)
Apr 26 2016CTVNActinium Pharmaceu ...Memorial Sloan-Kettering Cance ...10% OwnerSellS2.0719,75940,9015,483,0905.5 M to 5.5 M (-0.36 %)
Apr 26 2016CTVNActinium Pharmaceu ...Memorial Sloan-Kettering Cance ...10% OwnerSellS2.063,0416,2645,502,8495.5 M to 5.5 M (-0.06 %)
Apr 21 2016CTVNActinium Pharmaceu ...Memorial Sloan-Kettering Cance ...10% OwnerSellS2.053,7007,5855,505,8905.5 M to 5.5 M (-0.07 %)
Apr 21 2016CTVNActinium Pharmaceu ...Memorial Sloan-Kettering Cance ...10% OwnerSellS2.049,30018,9725,509,5905.5 M to 5.5 M (-0.17 %)
Apr 21 2016CTVNActinium Pharmaceu ...Memorial Sloan-Kettering Cance ...10% OwnerSellS2.0410,47321,3655,518,8905.5 M to 5.5 M (-0.19 %)
Apr 21 2016CTVNActinium Pharmaceu ...Memorial Sloan-Kettering Cance ...10% OwnerSellS2.0318,22436,9955,529,3635.5 M to 5.5 M (-0.33 %)
Apr 21 2016CTVNActinium Pharmaceu ...Memorial Sloan-Kettering Cance ...10% OwnerSellS2.024,0008,0805,547,5875.6 M to 5.5 M (-0.07 %)
Apr 21 2016CTVNActinium Pharmaceu ...Memorial Sloan-Kettering Cance ...10% OwnerSellS2.012004025,551,5875.6 M to 5.6 M (0.00 %)
Apr 21 2016CTVNActinium Pharmaceu ...Memorial Sloan-Kettering Cance ...10% OwnerSellS2.006001,2005,551,7875.6 M to 5.6 M (-0.01 %)
Apr 21 2016CTVNActinium Pharmaceu ...Memorial Sloan-Kettering Cance ...10% OwnerSellS2.073,4207,0805,552,3875.6 M to 5.6 M (-0.06 %)
Apr 21 2016CTVNActinium Pharmaceu ...Memorial Sloan-Kettering Cance ...10% OwnerSellS2.072,1334,4155,555,8075.6 M to 5.6 M (-0.04 %)
Apr 21 2016CTVNActinium Pharmaceu ...Memorial Sloan-Kettering Cance ...10% OwnerSellS2.074,5179,3285,557,9405.6 M to 5.6 M (-0.08 %)
Apr 21 2016CTVNActinium Pharmaceu ...Memorial Sloan-Kettering Cance ...10% OwnerSellS2.068,63317,7845,562,4575.6 M to 5.6 M (-0.15 %)
Apr 21 2016CTVNActinium Pharmaceu ...Memorial Sloan-Kettering Cance ...10% OwnerSellS2.0618,20037,4015,571,0905.6 M to 5.6 M (-0.33 %)
Apr 21 2016CTVNActinium Pharmaceu ...Memorial Sloan-Kettering Cance ...10% OwnerSellS2.053006155,589,2905.6 M to 5.6 M (-0.01 %)
Apr 21 2016CTVNActinium Pharmaceu ...Memorial Sloan-Kettering Cance ...10% OwnerSellS2.0533,30068,2655,589,5905.6 M to 5.6 M (-0.59 %)
Apr 21 2016CTVNActinium Pharmaceu ...Memorial Sloan-Kettering Cance ...10% OwnerSellS2.044,8009,7925,622,8905.6 M to 5.6 M (-0.09 %)
Apr 21 2016CTVNActinium Pharmaceu ...Memorial Sloan-Kettering Cance ...10% OwnerSellS2.032,5005,0755,627,6905.6 M to 5.6 M (-0.04 %)
Apr 21 2016CTVNActinium Pharmaceu ...Memorial Sloan-Kettering Cance ...10% OwnerSellS2.022,5005,0505,630,1905.6 M to 5.6 M (-0.04 %)
Apr 21 2016CTVNActinium Pharmaceu ...Memorial Sloan-Kettering Cance ...10% OwnerSellS2.0111,75123,6205,632,6905.6 M to 5.6 M (-0.21 %)
Apr 21 2016CTVNActinium Pharmaceu ...Memorial Sloan-Kettering Cance ...10% OwnerSellS2.015001,0035,644,4415.6 M to 5.6 M (-0.01 %)
Apr 21 2016CTVNActinium Pharmaceu ...Memorial Sloan-Kettering Cance ...10% OwnerSellS2.003757515,644,9415.6 M to 5.6 M (-0.01 %)
Apr 21 2016CTVNActinium Pharmaceu ...Memorial Sloan-Kettering Cance ...10% OwnerSellS2.007,56215,1255,645,3165.7 M to 5.6 M (-0.13 %)
Apr 21 2016CTVNActinium Pharmaceu ...Memorial Sloan-Kettering Cance ...10% OwnerSellS2.0049,50999,0185,652,8785.7 M to 5.7 M (-0.87 %)
Apr 18 2016CTVNActinium Pharmaceu ...Nicholson, C. DavidDirectorOption ExerciseA1.9975,000149,25075,000
Apr 18 2016CTVNActinium Pharmaceu ...Nicholson, C. DavidDirectorBuyP2.005,00010,00015,00010 K to 15 K (+50.00 %)
Apr 18 2016CTVNActinium Pharmaceu ...DAVE KAUSHIK JCEO and Interim CFOOption ExerciseA1.99400,000796,000400,000
Apr 18 2016CTVNActinium Pharmaceu ...DAVE KAUSHIK JCEO and Interim CFOBuyP2.012,0004,02088,50086.5 K to 88.5 K (+2.31 %)
Apr 18 2016CTVNActinium Pharmaceu ...DAVE KAUSHIK JCEO and Interim CFOBuyP2.028,00016,16086,50078.5 K to 86.5 K (+10.19 %)
Apr 18 2016CTVNActinium Pharmaceu ...SETH SANDESHDirectorOption ExerciseA1.99500,000995,000500,000
Apr 18 2016CTVNActinium Pharmaceu ...SETH SANDESHDirectorBuyP1.991,5002,98525,00023.5 K to 25 K (+6.38 %)
Apr 18 2016CTVNActinium Pharmaceu ...SETH SANDESHDirectorBuyP1.985,0009,90023,50018.5 K to 23.5 K (+27.03 %)
Apr 18 2016CTVNActinium Pharmaceu ...SETH SANDESHDirectorBuyP2.011,5003,01518,50017 K to 18.5 K (+8.82 %)
Apr 18 2016CTVNActinium Pharmaceu ...SETH SANDESHDirectorBuyP2.002,0004,00017,00015 K to 17 K (+13.33 %)
Apr 18 2016CTVNActinium Pharmaceu ...SETH SANDESHDirectorBuyP2.005,00010,00015,00010 K to 15 K (+50.00 %)
Apr 18 2016CTVNActinium Pharmaceu ...CICIC DRAGANChief Medical Offic ...Option ExerciseA1.9950,00099,50050,000
Apr 18 2016CTVNActinium Pharmaceu ...Steinhart Richard IDirectorOption ExerciseA1.9975,000149,25075,000
Apr 18 2016CTVNActinium Pharmaceu ...Steinhart Richard IDirectorBuyP2.012,5005,0252,5000 to 2.5 K
Apr 18 2016CTVNActinium Pharmaceu ...TRAVERSA SERGIODirectorOption ExerciseA1.9975,000149,25075,000
Apr 18 2016CTVNActinium Pharmaceu ...TRAVERSA SERGIODirectorBuyP2.021,0002,0203,0002 K to 3 K (+50.00 %)
Apr 18 2016CTVNActinium Pharmaceu ...TRAVERSA SERGIODirectorBuyP2.022,0004,0402,0000 to 2 K